Avanos Medical (AVNS) Other Non-Current Assets (2013 - 2026)

Avanos Medical has reported Other Non-Current Assets for 14 years, with the latest figure at $32.9 million in Q1 2026.

• Quarterly Other Non-Current Assets rose 29.53% year-over-year to $32.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.9 million (up 29.53% YoY) and the FY2025 annual result came in at $31.5 million, up 35.78% from the prior year.
• Other Non-Current Assets rose to $32.9 million in Q1 2026 per AVNS's latest filing, from $31.5 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $182.3 million in Q4 2022 and troughed at $15.9 million in Q1 2022.
• A 5-year average of $43.3 million and a median of $25.8 million in 2024 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets soared 1004.85% in 2022, then sank 74.73% in 2024.
• Over 5 years, Other Non-Current Assets stood at $182.3 million in 2022, then tumbled by 64.62% to $64.5 million in 2023, then tumbled by 64.03% to $23.2 million in 2024, then jumped by 35.78% to $31.5 million in 2025, then grew by 4.44% to $32.9 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $32.9 million, $31.5 million, and $29.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.